SEC Filings

Form DEFA14A Cullinan Therapeutics, May 16, 2024 06:43AM

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 14A

(Rule 14a-101)

Information Required in Proxy Statement

Schedule 14A Information

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

(Amendment No. )

 

 

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

Check the appropriate box:

 

☐   Preliminary Proxy Statement ☐  ... (continue reading...)

Form 6-K AENZA S.A.A. For: May 15 May 16, 2024 06:43AM

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN ISSUER

PURSUANT TO RULE 13a-16 OR 15b-16 OF

THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of May 2024

 

Commission File Number 001-35991

 

AENZA S.A.A.

(Exact name of registrant as specified in its charter)

 

N/A

(Translation of registrant’s name into English)

 

Av. Petit Thouars 4957

Miraflores

Lima 34, Peru

(Address of... (continue reading...)

Form 6-K ASTRAZENECA PLC For: May 16 May 16, 2024 06:42AM FORM 6-K   SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     Report of Foreign Issuer   Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934   For the month of May 2024   Commission File Number: 001-11960   AstraZeneca PLC   1 Francis Crick Avenue Cambridge Biomedical Campus Cambridge CB2 0AA United Kingdom     Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F... (continue reading...)

Form DEF 14A Cullinan Therapeutics, For: Jun 26 May 16, 2024 06:41AM Table of Contents

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 14A

(Rule 14a-101)

Information Required in Proxy Statement

Schedule 14A Information

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

 

 

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

Check the appropriate box:

 

☐    Preliminary Proxy Statement ☐    Confidential, for Use of... (continue reading...)

Form 6-K Greenfire Resources Ltd. For: May 16 May 16, 2024 06:38AM

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of May 2024.

 

Commission File Number 001-41810

 

Greenfire Resources Ltd.

(Exact name of Registrant as specified in its charter)

 

N/A

(Translation of Registrant’s name)

 

Suite 1900, 205 – 5th Avenue SW Calgary, Alberta T2P... (continue reading...)